Interdisciplinary team studying possible therapeutic pathways to prevent SARS-CoV-2 infection
The study, led by principal investigator Bruce Shenker, was awarded funding as part of a National Institutes of Health program to support supplemental COVID-19-related research, receiving a one-year grant extension to Shenker’s grant titled “Bacteria and lymphocyte suppression in periodontitis.”
FULL STORY AT Penn Dental Medicine →